Bruce G. Allen Investments LLC trimmed its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 21.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 851 shares of the financial services provider’s stock after selling 229 shares during the period. Bruce G. Allen Investments LLC’s holdings in MetLife were worth $70,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the business. MeadowBrook Investment Advisors LLC lifted its holdings in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. lifted its stake in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its position in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife during the 3rd quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC increased its stake in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday. Barclays lifted their target price on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday. JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday. Finally, TD Cowen boosted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $90.00.
MetLife Stock Down 3.1 %
NYSE MET traded down $2.59 on Friday, reaching $80.23. 2,662,978 shares of the stock traded hands, compared to its average volume of 2,851,820. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The company has a fifty day moving average price of $82.94 and a 200-day moving average price of $78.87. The company has a market cap of $55.55 billion, a price-to-earnings ratio of 16.18, a PEG ratio of 0.76 and a beta of 1.07.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.72%. The ex-dividend date is Tuesday, February 4th. MetLife’s payout ratio is 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is the Hang Seng index?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Consumer Discretionary Stocks Explained
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Plot Fibonacci Price Inflection Levels
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.